EDGAR Filing Documents for 0001213900-24-076184

Form 8-K - Current report:

SEC Accession No. 0001213900-24-076184

Filing Date

2024-09-05

Accepted

2024-09-05 17:18:25

Documents

Period of Report

2024-08-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea0213193-8k_orukathera.htm iXBRL	8-K	297575
2	CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF	ea021319301ex3-1_oruka.htm	EX-3.1	7601
3	CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF	ea021319301ex3-2_oruka.htm	EX-3.2	7602
4	CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF	ea021319301ex3-3_oruka.htm	EX-3.3	6489
5	CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF	ea021319301ex3-4_oruka.htm	EX-3.4	8875
6	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY, FILED SEPTEMBE	ea021319301ex3-5_oruka.htm	EX-3.5	26746
7	AMENDED AND RESTATED BYLAWS OF THE COMPANY	ea021319301ex3-6_oruka.htm	EX-3.6	152087
8	FORM OF CERTIFICATE OF ELIMINATION OF CERTIFICATE OF DESIGNATION OF PREFERENCES,	ea021319301ex3-8_oruka.htm	EX-3.8	9386
9	FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SER	ea021319301ex3-9_oruka.htm	EX-3.9	71073
10	ORUKA THERAPEUTICS, INC. 2024 STOCK INCENTIVE PLAN	ea021319301ex10-10_oruka.htm	EX-10.10	113469
11	ORUKA THERAPEUTICS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN	ea021319301ex10-11_oruka.htm	EX-10.11	82081
12	SECOND AMENDMENT TO AMENDED AND RESTATED ORUKA THERAPEUTICS, INC. 2024 EQUITY IN	ea021319301ex10-13_oruka.htm	EX-10.13	11652
13	FORM OF EMPLOYEE WARRANT AGREEMENT	ea021319301ex10-16_oruka.htm	EX-10.16	34388
14	CONSULTING AGREEMENT, EFFECTIVE AS OF AUGUST 30, 2024, BY AND BETWEEN ORUKA THER	ea021319301ex10-25_oruka.htm	EX-10.25	76344
15	CODE OF BUSINESS CONDUCT AND ETHICS OF ORUKA THERAPEUTICS, INC	ea021319301ex14-1_oruka.htm	EX-14.1	86667
16	LETTER FROM KPMG LLP, DATED SEPTEMBER 5, 2024	ea021319301ex16-1_oruka.htm	EX-16.1	2741
17	LIST OF SUBSIDIARIES OF ORUKA THERAPEUTICS, INC	ea021319301ex21-1_oruka.htm	EX-21.1	2260
18	PRESS RELEASE, ISSUED ON SEPTEMBER 3, 2024	ea021319301ex99-1_oruka.htm	EX-99.1	12993
19	AUDITED FINANCIAL STATEMENT OF ORUKA THERAPEUTICS, INC. AS OF FEBRUARY 6, 2024	ea021319301ex99-2_oruka.htm	EX-99.2	52736
20	UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF ORUKA THERAPEUT	ea021319301ex99-3_oruka.htm	EX-99.3	231546
21	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA	ea021319301ex99-4_oruka.htm	EX-99.4	150801
22	UNAUDITED PRO FORMA FINANCIAL STATEMENTS OF ORUKA THERAPEUTICS, INC. AND ARCA BI	ea021319301ex99-5_oruka.htm	EX-99.5	244728
23	GRAPHIC	ex14-1_001.jpg	GRAPHIC	6156
	Complete submission text file	0001213900-24-076184.txt		2261549

Data Files

Seq	Description	Document	Type	Size
24	XBRL SCHEMA FILE	orka-20240829.xsd	EX-101.SCH	3257
25	XBRL DEFINITION FILE	orka-20240829_def.xml	EX-101.DEF	26188
26	XBRL LABEL FILE	orka-20240829_lab.xml	EX-101.LAB	35952
27	XBRL PRESENTATION FILE	orka-20240829_pre.xml	EX-101.PRE	24846
38	EXTRACTED XBRL INSTANCE DOCUMENT	ea0213193-8k_orukathera_htm.xml	XML	5351

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025

Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910

Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)